Pharmacokinetics of cisplatin in semi-closed hyperthermic peritoneal perfusion (HPP) for treatment of peritoneal carcinomatosis.

Luigi Cattel(University of Turin), Laura Delprino(University of Turin), Michele De Simone(Université Claude Bernard Lyon 1), Maria Cristina Verlengo(University of Turin), Roberto Passera(Azienda Ospedaliera Citta' della Salute e della Scienza di Torino)

PubMed

September 9, 2004

Cited by 6

Related Papers

Revised International Staging System for Multiple Myeloma: A Report From International Myeloma Working Group

|Journal of Clinical Oncology|2015|2.2k

Next-generation sequencing and real-time quantitative PCR for minimal residual disease detection in B-cell disorders

|Leukemia|2013|305

Complete response correlates with long-term progression-free and overall survival in elderly myeloma treated with novel agents: analysis of 1175 patients

|Blood|2011|268

Major Tumor Shrinking and Persistent Molecular Remissions After Consolidation With Bortezomib, Thalidomide, and Dexamethasone in Patients With Autografted Myeloma

|Journal of Clinical Oncology|2010|268

Prospective, multicenter randomized GITMO/IIL trial comparing intensive (R-HDS) versus conventional (CHOP-R) chemoimmunotherapy in high-risk follicular lymphoma at diagnosis: the superior disease control of R-HDS does not translate into an overall survival advantage

|Blood|2008|253